The global market for Levofloxacin, a broad-spectrum fluoroquinolone antibiotic, is expected to experience double-digit revenue growth over the forecast period due to several factors. These include a growing incidence of bacterial infectious diseases, an increase in antibiotic resistance, and initiatives that promote awareness of diagnosis and prevention. Levofloxacin prophylaxis is also...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian